Surveillance and Treatment of Prisoners With Hepatitis C
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess how feasible it is to treat and prevent the
transmission of Hepatitis C in the prison setting to achieve substantial reductions in the
incidence and prevalence of Hepatitis C.
It is hypothesised that a rapid scale-up of Hepatitis C Virus (HCV) treatment with
interferon-free Direct Acting Anti-virals (DAAs) in prison inmates will achieve a >50%
reduction in the incidence of HCV infection over a two year period in the prison setting.